Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ufenamate Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Medical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ufenamate Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Medical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 450484 4200 Chemical & Material 377 179 Pages 4.7 (38)
                                          

Market Overview:


The global ufenamate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for ufenamate in research and medical applications, and increasing investments by key players in R&D activities. However, stringent regulatory norms may restrain the growth of the market. Based on type, the global ufenamate market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share of the global ufenamate market during the forecast period. This can be attributed to high demand for low-purity ufenamate products from research institutes and universities across regions. Based on application, the global ufenamate market is segmented into research, medical, and other applications. The medical application segment is expected to account for a major share of the global ufenamate market duringthe forecast period owingto growing demand for this product in hospitalsand clinicsfor various purposes such as pain reliefand treatmentof diseasessuch as cancerand arthritis.


Global Ufenamate Industry Outlook


Product Definition:


Ufenamate is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.


Min Purity Less Than 98%:


Ufenamate is a chemical, which is used as a precursor to the manufacture of pesticides and other agrochemicals. Min Purity Less Than 98% refers to the purity of ufenamate in pesticide form. It's an oily liquid with no color and odor.


Min Purity 98%-99%:


Min Purity 98%-99% is a special type of Enzyme Enzymes (EE) that are used in the production of Ufenamate, an insecticide. It is also used as a feed supplement for poultry and livestock. The product contains almost no impurities and has less than 0.5% moisture content by weight which makes it ideal for use in high-performance liquid formulations such as fumigants, bactericides, fungicides, etc.


Application Insights:


The research application segment led the global ufenamate market in 2017 and is projected to witness significant growth over the forecast period. This can be attributed to growing R&D activities pertaining to health supplements, functional foods and dietary supplements. For instance, in January 2018, Phenylalanine ammonia-based Company announced about its new product launch - ¢â‚¬Å“Phenylalanine HCI Capsule¢â‚¬ which was designed for people who have difficulty in getting a good night sleep due to anxiety or stress. The company has also plans of introducing this product line into various other segments such as weight loss & fitness, immunity support among others.


Ufenamates are used for manufacturing medicines that treat depression (Sufenon), attention deficit hyperactivity disorder (ADHD) (Adzenys), obesity (Orlistat).


Regional Analysis:


Asia Pacific was the largest regional market in 2017 and is anticipated to maintain its position throughout the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare spending by the governments, which subsequently leads to an increased demand for ufenamate drugs. In addition, growing awareness regarding various diseases and their treatment options through modern medicines is expected to fuel product demand in this region.


The Asia Pacific market was followed by Europe with a share of over 20%. This can be attributed to high manufacturing capacity as well as high exports from China, India, Japan, South Korea & Taiwan among other countries owing to low production costs coupled with easy availability of raw materials such as furfuryl alcohol.


Growth Factors:


  • Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of around 7% during the forecast period, which will drive the demand for ufenamate products.
  • Rising prevalence of arthritis and other musculoskeletal disorders: Arthritis is one of the most common chronic diseases, which leads to inflammation and pain in joints. It is estimated that over 350 million people are affected by arthritis worldwide, thereby driving the demand for ufenamate products.
  • Growing awareness about pain management therapies: There has been an increase in awareness about various pain management therapies among consumers in recent years. This has led to an increase in adoption of ufenamate products for relief from various types of pain conditions.
  • Technological advancements in analgesic drugs: There have been several advancements made recently in analgesic drugs, owing to which they are becoming more effective and safer than ever before. This is likely to result in an increased adoption rate of ufenamate products across the globe over the next few years.. 5) Availability of generic versions: A number if generic versions o fufenamide are available at lower prices as compared t o branded counterparts, making them more affordable for consumers

Scope Of The Report

Report Attributes

Report Details

Report Title

Ufenamate Market Research Report

By Type

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

By Application

Research, Medical

By Companies

Biorbyt, BOC Sciences, Ark Pharm, United States Biological, TCI, Clearsynth, Selleck Chemicals, Biosynth Carbosynth, Adooq Bioscience, Target Molecule, J&K Scientific

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

179

Number of Tables & Figures

126

Customization Available

Yes, the report can be customized as per your need.


Global Ufenamate Market Report Segments:

The global Ufenamate market is segmented on the basis of:

Types

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Research, Medical

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Biorbyt
  2. BOC Sciences
  3. Ark Pharm
  4. United States Biological
  5. TCI
  6. Clearsynth
  7. Selleck Chemicals
  8. Biosynth Carbosynth
  9. Adooq Bioscience
  10. Target Molecule
  11. J&K Scientific

Global Ufenamate Market Overview


Highlights of The Ufenamate Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Min Purity Less Than 98%
    2. Min Purity 98%-99%
    3. Min Purity More Than 99%
  1. By Application:

    1. Research
    2. Medical
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ufenamate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ufenamate Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Ufenamate is a medication used to treat anxiety and depression. It works by changing the way the brain processes information.

Some of the major players in the ufenamate market are Biorbyt, BOC Sciences, Ark Pharm, United States Biological, TCI, Clearsynth, Selleck Chemicals, Biosynth Carbosynth, Adooq Bioscience, Target Molecule, J&K Scientific.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ufenamate Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Ufenamate Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Ufenamate Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Ufenamate Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Ufenamate Market Size & Forecast, 2020-2028       4.5.1 Ufenamate Market Size and Y-o-Y Growth       4.5.2 Ufenamate Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Min Purity Less Than 98%
      5.2.2 Min Purity 98%-99%
      5.2.3 Min Purity More Than 99%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Research
      6.2.2 Medical
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Ufenamate Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Ufenamate Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Min Purity Less Than 98%
      9.6.2 Min Purity 98%-99%
      9.6.3 Min Purity More Than 99%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Research
      9.10.2 Medical
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Min Purity Less Than 98%
      10.6.2 Min Purity 98%-99%
      10.6.3 Min Purity More Than 99%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Research
      10.10.2 Medical
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Min Purity Less Than 98%
      11.6.2 Min Purity 98%-99%
      11.6.3 Min Purity More Than 99%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Research
      11.10.2 Medical
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Min Purity Less Than 98%
      12.6.2 Min Purity 98%-99%
      12.6.3 Min Purity More Than 99%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Research
      12.10.2 Medical
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Min Purity Less Than 98%
      13.6.2 Min Purity 98%-99%
      13.6.3 Min Purity More Than 99%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Research
      13.10.2 Medical
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Ufenamate Market: Competitive Dashboard
   14.2 Global Ufenamate Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Biorbyt
      14.3.2 BOC Sciences
      14.3.3 Ark Pharm
      14.3.4 United States Biological
      14.3.5 TCI
      14.3.6 Clearsynth
      14.3.7 Selleck Chemicals
      14.3.8 Biosynth Carbosynth
      14.3.9 Adooq Bioscience
      14.3.10 Target Molecule
      14.3.11 J&K Scientific

Our Trusted Clients

Contact Us